List of Excipients in API RIBAVIRIN
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing RIBAVIRIN
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp | REBETOL | ribavirin | 0085-1351 | ALCOHOL | |
| Merck Sharp & Dohme Corp | REBETOL | ribavirin | 0085-1351 | ALUMINUM OXIDE | |
| Merck Sharp & Dohme Corp | REBETOL | ribavirin | 0085-1351 | AMMONIA | |
| Merck Sharp & Dohme Corp | REBETOL | ribavirin | 0085-1351 | BUTYL ALCOHOL | |
| Merck Sharp & Dohme Corp | REBETOL | ribavirin | 0085-1351 | CELLULOSE, MICROCRYSTALLINE | |
| Merck Sharp & Dohme Corp | REBETOL | ribavirin | 0085-1351 | CROSCARMELLOSE SODIUM | |
| Merck Sharp & Dohme Corp | REBETOL | ribavirin | 0085-1351 | FD&C BLUE NO. 2 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing RIBAVIRIN
Detailed excipient profiles for RIBAVIRIN
Excipient focus: ALCOHOL
RIBAVIRIN drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | ribavirin | 0085-1351 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing ALCOHOL
Excipient focus: ALUMINUM OXIDE
RIBAVIRIN drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | ribavirin | 0085-1351 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing ALUMINUM OXIDE
Excipient focus: AMMONIA
RIBAVIRIN drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | ribavirin | 0085-1351 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing AMMONIA
Excipient focus: BUTYL ALCOHOL
RIBAVIRIN drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | ribavirin | 0085-1351 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing BUTYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
RIBAVIRIN drug variants containing CELLULOSE, MICROCRYSTALLINE
RIBAVIRIN drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0781 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
RIBAVIRIN drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | ribavirin | 0085-1351 |
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0781 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
RIBAVIRIN drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0782 |
| Zydus Lifesciences Limited | ribavirin | 65841-046 |
| Zydus Lifesciences Limited | ribavirin | 65841-260 |
| Zydus Pharmaceuticals USA Inc | ribavirin | 68382-046 |
| Zydus Pharmaceuticals USA Inc | ribavirin | 68382-260 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | ribavirin | 0085-1351 |
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0781 |
| Aurobindo Pharma Limited | ribavirin | 65862-207 |
| Aurobindo Pharma Limited | ribavirin | 65862-290 |
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE
RIBAVIRIN drug variants containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | ribavirin | 65862-207 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing ETHYLCELLULOSE
Excipient focus: FD&C BLUE NO. 1
RIBAVIRIN drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0781 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
RIBAVIRIN drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | ribavirin | 0085-1351 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing FD&C BLUE NO. 2
Excipient focus: FERRIC OXIDE RED
RIBAVIRIN drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0782 |
| Zydus Lifesciences Limited | ribavirin | 65841-046 |
| Aurobindo Pharma Limited | ribavirin | 65862-207 |
| Zydus Pharmaceuticals USA Inc | ribavirin | 68382-046 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | ribavirin | 0085-1351 |
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0781 |
| Zydus Lifesciences Limited | ribavirin | 65841-260 |
| Aurobindo Pharma Limited | ribavirin | 65862-290 |
| Zydus Pharmaceuticals USA Inc | ribavirin | 68382-260 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
RIBAVIRIN drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0782 |
| Zydus Lifesciences Limited | ribavirin | 65841-046 |
| Aurobindo Pharma Limited | ribavirin | 65862-207 |
| Zydus Pharmaceuticals USA Inc | ribavirin | 68382-046 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | ribavirin | 0085-1351 |
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0781 |
| Zydus Lifesciences Limited | ribavirin | 65841-260 |
| Aurobindo Pharma Limited | ribavirin | 65862-290 |
| Zydus Pharmaceuticals USA Inc | ribavirin | 68382-260 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
RIBAVIRIN drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | ribavirin | 65862-290 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
RIBAVIRIN drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | ribavirin | 0085-1351 |
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0781 |
| Zydus Lifesciences Limited | ribavirin | 65841-260 |
| Aurobindo Pharma Limited | ribavirin | 65862-290 |
| Zydus Pharmaceuticals USA Inc | ribavirin | 68382-260 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0782 |
| Zydus Lifesciences Limited | ribavirin | 65841-046 |
| Aurobindo Pharma Limited | ribavirin | 65862-207 |
| Zydus Pharmaceuticals USA Inc | ribavirin | 68382-046 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
RIBAVIRIN drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0781 |
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0782 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
RIBAVIRIN drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | ribavirin | 65862-207 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
RIBAVIRIN drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Lifesciences Limited | ribavirin | 65841-046 |
| Zydus Pharmaceuticals USA Inc | ribavirin | 68382-046 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL ALCOHOL
RIBAVIRIN drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | ribavirin | 0085-1351 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE MONOHYDRATE
RIBAVIRIN drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | ribavirin | 0085-1351 |
| Aurobindo Pharma Limited | ribavirin | 65862-290 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
RIBAVIRIN drug variants containing MAGNESIUM STEARATE
RIBAVIRIN drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
RIBAVIRIN drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0781 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing MANNITOL
Excipient focus: POLYETHYLENE GLYCOL
RIBAVIRIN drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0782 |
| Zydus Lifesciences Limited | ribavirin | 65841-046 |
| Zydus Pharmaceuticals USA Inc | ribavirin | 68382-046 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POVIDONE
RIBAVIRIN drug variants containing POVIDONE
RIBAVIRIN drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | ribavirin | 0085-1351 |
| Aurobindo Pharma Limited | ribavirin | 65862-207 |
| Aurobindo Pharma Limited | ribavirin | 65862-290 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
RIBAVIRIN drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | ribavirin | 65862-207 |
| Aurobindo Pharma Limited | ribavirin | 65862-290 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
RIBAVIRIN drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | ribavirin | 0085-1351 |
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0781 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
RIBAVIRIN drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | ribavirin | 0085-1351 |
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0781 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
RIBAVIRIN drug variants containing SILICON DIOXIDE
RIBAVIRIN drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0781 |
| Aurobindo Pharma Limited | ribavirin | 65862-290 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
RIBAVIRIN drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | ribavirin | 0085-1351 |
| Aurobindo Pharma Limited | ribavirin | 65862-290 |
| Zydus Pharmaceuticals USA Inc | ribavirin | 68382-260 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
RIBAVIRIN drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | ribavirin | 65862-207 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
RIBAVIRIN drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | ribavirin | 65862-207 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing STARCH, CORN
Excipient focus: TALC
RIBAVIRIN drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | ribavirin | 53808-0782 |
| Zydus Lifesciences Limited | ribavirin | 65841-046 |
| Zydus Pharmaceuticals USA Inc | ribavirin | 68382-046 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
RIBAVIRIN drug variants containing TITANIUM DIOXIDE
RIBAVIRIN drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
RIBAVIRIN drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | ribavirin | 65862-207 |
| >Company | >Ingredient | >NDC |
RIBAVIRIN drug variants not containing TRIACETIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
